Over the last decade, several populations of B cells with regulatory functions have been identified in an increasing number of pathological conditions. Since for several years we have been interested in a population of kidney transplant patients tolerant to their graft, we wanted to explore this regulatory process in these patients. After having shown that tolerant patients had a transcriptional profile with a strong B lymphocyte imprint, we showed that they had a higher number of B cells expressing granzyme B capable of inhibiting the proliferation of effector T cells by a mechanism depending on the contact of the B lymphocyte with its target and on granzyme B. We characterized these B lymphocytes and were able to establish a protocol for the expansion of these cells allowing us to consider their future use in cell therapy.
No takes yet. Share an insight, caveat, or question.
Sophie Brouard (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: